Hiperglucemia y obesidad

1 World Health Organization. Obesity and overweight. 2021. www. who.int/news-room/fact-sheets/detail/obesity-and-overweight [Accessed 20 June 2023].

2 World Health Organization. Diabetes. 2022. www.who.int/news-room/fact-sheets/detail/diabetes [Accessed 20 June 2023].

3 Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790–7.

4 Edelstein SL, Knowler WC, Bain RP et al. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997;46:701–10.

5 Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840–6.

6 Chalkley SM, Kraegen EW, Furler SM et al. NEFA elevation during a hyperglycaemic clamp enhances insulin secretion. Diabet Med 1998;15:327–33.

7 Leung N, Sakaue T, Carpentier A. Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 2004;47:204–13.

8 Day C, Bailey CJ. Obesity in the pathogenesis of type 2 diabetes. Br J Diabetes Vascul Dis 2011;11:55–61.

9 Saeedi P, Salpea P, Karuranga S et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract 2020;162:108086.

10 Saaristo TE, Barengo NC, Korpi-Hyövälti E et al. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. BMC Public Health 2008;8:423.

11 Pedersen SD. Metabolic complications of obesity. Best Pract Res Clin Endocrinol Metab 2013;27:179–93.

12 Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med 2017;5:161.

13 Singh R, Rathore SS, Khan H et al. Association of obesity with COVID-19 severity and mortality: an updated systemic review, meta-analysis, and meta-regression. Front Endocrinol (Lausanne) 2022;13:780872.

14 Moosaie F, Ghaemi F, Mechanick JI et al. Obesity and diabetic complications: a study from the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (NPPCD- 2021) Implications for Action on Multiple Scales. Prim Care Diabetes 2022;16:422–9.

15 Rock CL, Flatt SW, Pakiz B et al. Weight loss, glycemic control, and cardiovascular disease risk factors in response to differential diet composition in a weight loss program in type 2 diabetes: a randomized controlled trial. Diabetes Care 2014;37:1573–80.

16 Wing RR, Koeske R, Epstein LH et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749–53.

17 Lean ME, Leslie WS, Barnes AC et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 2018;391:541–51.

18 Goodpaster BH, Kelley DE, Wing RR et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999;48:839–47.

19 Ferrannini E, Camastra S, Gastaldelli A et al. Beta-cell function in obesity: effects of weight loss. Diabetes 2004;53:S26–33.

20 Franssila-Kallunki A, Rissanen A, Ekstrand A et al. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. Am J Clin Nutr 1992;55:356–61.

21 Gregg EW, Gerzoff RB, Thompson TJ et al. Trying to lose weight, losing weight, and 9-year mortality in overweight U.S. adults with diabetes. Diabetes Care 2004;27:657–62.

2 Chaturvedi N, Fuller JH. Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care 1995;18:766–74.

23 Storck LJ, Meffert PJ, Rausch J et al. Efficiency of a 15-week weight-loss program, including a low-calorie formula diet, on glycemic control in patients with type 2 diabetes mellitus and overweight or obesity. Obes Facts 2021;14:1–11.

24 Esposito K, Maiorino MI, Petrizzo M et al. The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomised trial. Diabetes Care 2014;37:1824–30.

25 Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985;61:917–25.

26 Allen FM, Stillman E, Fitz R. Total dietary regulation in the treatment of diabetes. New York: Rockefeller Institute for Medical Research; 1919.

27 Laaksonen DE, Lindström J, Lakka TA et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005;54:158–65.

28 Gong Q, Zhang P, Wang J et al. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 2019;7:452–61.